140 related articles for article (PubMed ID: 15115874)
21. Expression of p21WAF1/CIP1 in adenocarcinoma of the uterine cervix: a possible immunohistochemical marker of a favorable prognosis.
Lu X; Toki T; Konishi I; Nikaido T; Fujii S
Cancer; 1998 Jun; 82(12):2409-17. PubMed ID: 9635534
[TBL] [Abstract][Full Text] [Related]
22. Control of cell cycle progression in human mesothelioma cells treated with gamma interferon.
Vivo C; Lévy F; Pilatte Y; Fleury-Feith J; Chrétien P; Monnet I; Kheuang L; Jaurand MC
Oncogene; 2001 Mar; 20(9):1085-93. PubMed ID: 11314045
[TBL] [Abstract][Full Text] [Related]
23. Clinical relevance of expression of the CIP/KIP cell-cycle inhibitors p21 and p27 in laryngeal cancer.
Pruneri G; Pignataro L; Carboni N; Buffa R; Di Finizio D; Cesana BM; Neri A
J Clin Oncol; 1999 Oct; 17(10):3150-9. PubMed ID: 10506612
[TBL] [Abstract][Full Text] [Related]
24. Expression profiling of colorectal carcinomas using tissue microarrays: cell cycle regulatory proteins p21, p27, and p53 as immunohistochemical prognostic markers in univariate and multivariate analysis.
Prall F; Ostwald C; Nizze H; Barten M
Appl Immunohistochem Mol Morphol; 2004 Jun; 12(2):111-21. PubMed ID: 15354735
[TBL] [Abstract][Full Text] [Related]
25. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
26. May cyclooxygenase-2 (COX-2), p21 and p27 expression affect prognosis and therapeutic strategy of patients with malignant pleural mesothelioma?
Mineo TC; Ambrogi V; Cufari ME; Pompeo E
Eur J Cardiothorac Surg; 2010 Sep; 38(3):245-52. PubMed ID: 20338775
[TBL] [Abstract][Full Text] [Related]
27. Reduced p21, p27 and vitamin D receptor in the nodular hyperplasia in patients with advanced secondary hyperparathyroidism.
Tokumoto M; Tsuruya K; Fukuda K; Kanai H; Kuroki S; Hirakata H
Kidney Int; 2002 Oct; 62(4):1196-207. PubMed ID: 12234290
[TBL] [Abstract][Full Text] [Related]
28. The prognostic significance of p53, p27 kip1, p21 waf1, HER-2/neu, and Ki67 proteins expression in gastric cancer: a clinicopathological and immunohistochemical study of 121 Arab patients.
Al-Moundhri MS; Nirmala V; Al-Hadabi I; Al-Mawaly K; Burney I; Al-Nabhani M; Thomas V; Ganguly SS; Grant C
J Surg Oncol; 2005 Sep; 91(4):243-52. PubMed ID: 16121348
[TBL] [Abstract][Full Text] [Related]
29. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
[TBL] [Abstract][Full Text] [Related]
30. Expression of p21 cell cycle protein is an independent predictor of response to salvage radiotherapy after radical prostatectomy.
Rigaud J; Tiguert R; Decobert M; Hovington H; Latulippe E; Laverdiere J; Larue H; Lacombe L; Fradet Y
Prostate; 2004 Feb; 58(3):269-76. PubMed ID: 14743466
[TBL] [Abstract][Full Text] [Related]
31. p53, p21 and p27 protein expression in head and neck cancer and their prognostic value.
Kapranos N; Stathopoulos GP; Manolopoulos L; Kokka E; Papadimitriou C; Bibas A; Yiotakis J; Adamopoulos G
Anticancer Res; 2001; 21(1B):521-8. PubMed ID: 11299798
[TBL] [Abstract][Full Text] [Related]
32. Aberrant expression of cell cycle regulatory genes predicts overall and disease free survival in malignant pleural mesothelioma patients.
Bahnassy AA; Zekri AR; Abou-Bakr AA; El-Deftar MM; El-Bastawisy A; Sakr MA; El-Sherif GM; Gaafar RM
Exp Mol Pathol; 2012 Aug; 93(1):154-61. PubMed ID: 22504106
[TBL] [Abstract][Full Text] [Related]
33. Cyclooxygenase-2 expression is a novel prognostic factor in malignant mesothelioma.
Edwards JG; Faux SP; Plummer SM; Abrams KR; Walker RA; Waller DA; O'Byrne KJ
Clin Cancer Res; 2002 Jun; 8(6):1857-62. PubMed ID: 12060628
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical expression of cyclin D1, cyclin E, p21/waf1 and p27/kip1 in inflammatory bowel disease: correlation with other cell-cycle-related proteins (Rb, p53, ki-67 and PCNA) and clinicopathological features.
Ioachim EE; Katsanos KH; Michael MC; Tsianos EV; Agnantis NJ
Int J Colorectal Dis; 2004 Jul; 19(4):325-33. PubMed ID: 15060836
[TBL] [Abstract][Full Text] [Related]
35. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1.
Korkolopoulou P; Christodoulou P; Konstantinidou AE; Thomas-Tsagli E; Kapralos P; Davaris P
Hum Pathol; 2000 Jun; 31(6):751-60. PubMed ID: 10872671
[TBL] [Abstract][Full Text] [Related]
36. Novel target for induction of apoptosis by cyclo-oxygenase-2 inhibitor SC-236 through a protein kinase C-beta(1)-dependent pathway.
Jiang XH; Lam SK; Lin MC; Jiang SH; Kung HF; Slosberg ED; Soh JW; Weinstein IB; Wong BC
Oncogene; 2002 Sep; 21(39):6113-22. PubMed ID: 12203123
[TBL] [Abstract][Full Text] [Related]
37. p27: a potential main inhibitor of cell proliferation in digestive endocrine tumors but not a marker of benign behavior.
Canavese G; Azzoni C; Pizzi S; Corleto VD; Pasquali C; Davoli C; Crafa P; Delle Fave G; Bordi C
Hum Pathol; 2001 Oct; 32(10):1094-101. PubMed ID: 11679944
[TBL] [Abstract][Full Text] [Related]
38. Altered expression of cell cycle regulators p21, p27, and p53 in tumors of salivary glands and paranasal sinuses.
Affolter A; Helmbrecht S; Finger S; Hörmann K; Götte K
Oncol Rep; 2005 Jun; 13(6):1089-94. PubMed ID: 15870926
[TBL] [Abstract][Full Text] [Related]
39. Expression of p27(KIP1) and p21(WAF1/CIP1) in primary hepatocellular carcinoma: clinicopathologic correlation and survival analysis.
Qin LF; Ng IO
Hum Pathol; 2001 Aug; 32(8):778-84. PubMed ID: 11521219
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of p21 and p27 protein, apoptosis, clinical and histologic factors in rectal cancer without lymph node metastases.
Schwandner O; Bruch HP; Broll R
Eur Surg Res; 2002; 34(6):389-96. PubMed ID: 12403937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
